Category: Latest News
-
Oracle Shares Jump After Earnings Beat and Higher Revenue Outlook
Oracle Corporation (NYSE:ORCL) reported quarterly results on Tuesday that exceeded analysts’ expectations for both revenue and profit, driven by continued strong expansion in its cloud computing business. The company also lifted its fiscal 2027 revenue forecast, pushing its shares roughly 10% higher in premarket trading on Wednesday. The Austin, Texas-based technology group has increasingly focused…
-
Oil prices swing as markets assess possible IEA reserve release and ongoing supply risks
Oil prices moved higher on Wednesday as traders questioned whether a reported plan by the International Energy Agency to release record levels of emergency reserves would be enough to counter potential supply disruptions linked to the U.S.-Israeli conflict with Iran. Brent crude futures rose 59 cents, or 0.7%, to $88.39 per barrel by 07:27 GMT.…
-
Markets Watch Oil Volatility, Middle East Conflict and CPI Data; Oracle Lifts Outlook: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. equity futures traded slightly below the flatline on Wednesday as investors monitored the uncertain trajectory of the conflict in the Middle East. Oil prices swung following reports that the International Energy Agency could release a record volume of emergency reserves, while markets also awaited key U.S. inflation data later in the day. Meanwhile, Oracle…
-
U.S. Stocks Finish Choppy Trading Day Little Changed
After recovering from an early sell-off to end Monday’s session mostly higher, stocks showed a lack of direction over the course of the trading day on Tuesday. The major averages spent the day bouncing back and forth across the unchanged line. The major averages eventually ended the day narrowly mixed. While the Nasdaq inched up…
-
Aptevo Shares Drop Despite Encouraging AML Trial Results
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares plunged about 18% on Tuesday even after the company reported promising interim clinical results for its acute myeloid leukemia (AML) treatment candidate, mipletamig. The clinical-stage biotech said mipletamig, when combined with venetoclax and azacitidine, achieved an 86% clinical benefit rate in newly diagnosed AML patients who are elderly or considered…
-
Celularity Strikes Up to $35M Licensing Deal for Biomaterials Portfolio
Celularity Inc. (NASDAQ:CELU) announced it has signed agreements for a strategic commercialization partnership involving its placental-derived biomaterials portfolio, a transaction that could generate up to $35 million through upfront and milestone-based payments. The deal, expected to close by April 15, 2026, grants an exclusive license to Celularity’s commercial-stage biomaterials products along with certain development-stage programs.…
-
Rivian Shares Rise After TD Cowen Upgrade Ahead of R2 Launch
Rivian Automotive (NASDAQ:RIVN) shares gained about 5% Tuesday morning after TD Cowen upgraded the electric vehicle maker to Buy from Hold and set a $20 price target. The stock had closed Monday’s session at $15.87. The upgrade followed a detailed demand assessment of Rivian’s upcoming R2 model conducted by TD Cowen analyst Itay Michaeli. Michaeli…
-
Zoom Expands AI Platform With New Workflow Automation Features
Zoom Communications Inc. (NASDAQ:ZM) announced an expansion of its enterprise artificial intelligence platform, introducing new workflow orchestration capabilities designed to automate tasks across its Workplace, Phone and customer experience products. The new features allow organizations to trigger automated actions and cross-system workflows directly from meetings, calls and customer interactions, integrating collaboration tools with broader enterprise…
-
IBM and Lam Research Team Up to Advance Sub-1nm Chip Technology
IBM (NYSE:IBM) and Lam Research Corp. (NASDAQ:LRCX) have announced a five-year partnership focused on developing next-generation semiconductor processes and materials for logic scaling below the 1-nanometer threshold. The collaboration will concentrate on creating new materials, fabrication techniques and High NA EUV lithography processes aimed at advancing IBM’s long-term logic scaling roadmap. The joint effort will…
-
Citigroup CEO Says Q1 Investment Banking Fees Tracking Mid-Teens Growth
Citigroup Inc. (NYSE:C) Chief Executive Officer Jane Fraser said Tuesday that the bank’s investment banking fees are on track to rise by a mid-teens percentage in the first quarter compared with the same period last year. Speaking at an RBC conference, Fraser added that Citigroup’s markets division is also expected to post growth in the…